For example, Zhang et al. identified GLUL, NCF2, S100A12, and SRGN as significant biomarkers associated with AF and heart failure (HF), providing a foundation for clinical diagnosis and treatment (24). This evidence concerns the gene SRGN and atrial fibrillation.